isosorbide dinitrate has been researched along with allopurinol in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Laakso, J; Lapatto, R; Mervaala, E; Vapaatalo, H; Vaskonen, T | 1 |
| Bollmann, F; Daiber, A; Gori, T; Hausding, M; Heeren, T; Kleinert, H; Knorr, M; Münzel, T; Oelze, M; Otto, C; Pautz, A; Reifenberg, K; Schuhmacher, S; Schulz, E; Steven, S; Wenzel, P | 1 |
| Chen, L; Cong, J; Guo, R; Guo, X; Liu, Z; Yi, D; Zhang, B | 1 |
1 review(s) available for isosorbide dinitrate and allopurinol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for isosorbide dinitrate and allopurinol
| Article | Year |
|---|---|
CGRP mediate the isosorbide-5-mononitrate cardiovascular response in healthy Chinese male volunteers through a XOR-independent pathway.
Topics: Administration, Oral; Adult; Allopurinol; Antihypertensive Agents; Asian People; Blood Pressure; Calcitonin Gene-Related Peptide; Cells, Cultured; China; Enzyme Inhibitors; Healthy Volunteers; Humans; Isosorbide Dinitrate; Leukocytes, Mononuclear; Male; RNA, Messenger; Signal Transduction; Vasodilator Agents; Xanthine Oxidase | 2015 |
7 other study(ies) available for isosorbide dinitrate and allopurinol
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Inhibition of nitric oxide synthase induces renal xanthine oxidoreductase activity in spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Enzyme Inhibitors; Hypertension; Isosorbide Dinitrate; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Donors; Nitric Oxide Synthase; Rats; Rats, Inbred SHR; Sodium Chloride, Dietary; Xanthine Dehydrogenase; Xanthine Oxidase | 1999 |
Vascular dysfunction in experimental diabetes is improved by pentaerithrityl tetranitrate but not isosorbide-5-mononitrate therapy.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Endothelium, Vascular; Gene Silencing; GTP Cyclohydrolase; Heme Oxygenase-1; Isosorbide Dinitrate; Male; NADPH Oxidases; Oxidative Stress; Pentaerythritol Tetranitrate; Rats; Rats, Wistar; Reactive Oxygen Species; Vasoconstriction; Vasodilator Agents; Weight Gain; Xanthine Oxidase | 2011 |